Co-Authors
This is a "connection" page, showing publications co-authored by Paul Ruff and Maureen Joffe.
Connection Strength
3,156
-
Associations between HIV infection status, psychosocial factors, and adjuvant endocrine therapy adherence among South African women with early-stage breast cancer. Res Sq. 2024 Jun 27.
Score: 0,240
-
Perspectives on common chronic diseases in adult cancer patients in South Africa. Glob Health Action. 2023 12 31; 16(1):2228567.
Score: 0,232
-
The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approaches. PLOS Glob Public Health. 2023; 3(10):e0002432.
Score: 0,229
-
Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort. PLoS One. 2023; 18(2):e0281916.
Score: 0,218
-
Survival of south african women with breast cancer receiving anti-retroviral therapy for HIV. Breast. 2021 Oct; 59:27-36.
Score: 0,194
-
Consensus study on the health system and patient-related barriers for lung cancer management in South Africa. PLoS One. 2021; 16(2):e0246716.
Score: 0,190
-
A Prospective Cohort Study of Factors Associated With Place of Death Among Patients With Late-Stage Cancer in Southern Africa. J Pain Symptom Manage. 2019 05; 57(5):923-932.
Score: 0,165
-
Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV. Breast. 2019 Feb; 43:123-129.
Score: 0,163
-
Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa. Cancer Manag Res. 2018; 10:279-286.
Score: 0,154
-
Barriers to early presentation of breast cancer among women in Soweto, South Africa. PLoS One. 2018; 13(2):e0192071.
Score: 0,154
-
Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11. Cancer Epidemiol. 2018 02; 52:120-127.
Score: 0,153
-
FGFR2 genetic variants in women with breast cancer. Mol Med Rep. 2023 Dec; 28(6).
Score: 0,057
-
The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer. Oncologist. 2023 10 03; 28(10):e921-e929.
Score: 0,057
-
PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study. Breast Cancer Res Treat. 2023 Aug; 200(3):337-346.
Score: 0,056
-
Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co-Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer. Clin Pharmacol Ther. 2023 07; 114(1):127-136.
Score: 0,055
-
Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Res Treat. 2023 May; 199(1):1-12.
Score: 0,055
-
Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study. Breast Cancer Res. 2023 01 23; 25(1):7.
Score: 0,054
-
The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Res Treat. 2023 Feb; 197(3):647-659.
Score: 0,054
-
Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2192-2198.
Score: 0,054
-
The Impact of Breast Cancer Treatment Delays on Survival Among South African Women. Oncologist. 2022 03 11; 27(3):e233-e243.
Score: 0,051
-
Impact of HIV infection on survival among women with stage I-III breast cancer: Results from the South African breast cancer and HIV outcomes study. Int J Cancer. 2022 Jul 15; 151(2):209-221.
Score: 0,051
-
Validating an Instrument for Direct Patient Reporting of Distress and Chemotherapy-Related Toxicity among South African Cancer Patients. Cancers (Basel). 2021 Dec 24; 14(1).
Score: 0,050
-
Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa. Breast Cancer Res Treat. 2021 Aug; 189(1):285-296.
Score: 0,049
-
Quality of Histopathological Reporting in Breast Cancer: Results From Four South African Breast Units. JCO Glob Oncol. 2021 01; 7:72-80.
Score: 0,047
-
A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection. Breast Cancer Res Treat. 2020 Dec; 184(3):861-872.
Score: 0,046
-
Spiritual Care, Pain Reduction, and Preferred Place of Death Among Advanced Cancer Patients in Soweto, South Africa. J Pain Symptom Manage. 2020 07; 60(1):37-47.
Score: 0,044
-
Breast Cancer Care Quality in South Africa's Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures. J Glob Oncol. 2019 11; 5:1-16.
Score: 0,043
-
The multimorbidity profile of South African women newly diagnosed with breast cancer. Int J Cancer. 2020 07 15; 147(2):361-374.
Score: 0,043
-
Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy. Oncologist. 2019 07; 24(7):933-944.
Score: 0,041
-
Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol. 2018 09; 4:1-9.
Score: 0,040
-
Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death. J Pain Symptom Manage. 2018 07; 56(1):98-106.
Score: 0,039
-
Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa. PLoS One. 2017; 12(8):e0182125.
Score: 0,037
-
South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment. J Glob Oncol. 2017 Apr; 3(2):114-124.
Score: 0,036